Predictors of death and occurrence of appropriate implantable defibrillator therapies in patients with ischemic cardiomyopathy
Most patients with chronic ischemia and an implantable cardiac defibrillator (ICD) for primary prevention do not experience therapies for ventricular arrhythmias on follow-up. The present study aimed to identify independent clinical, electrocardiographic, and echocardiographic predictors of death and occurrence of ICD therapy in patients with chronic ischemic cardiomyopathy and ICD for primary prevention. A total of 424 patients with chronic ischemic cardiomyopathy, ejection fraction ≤35%, and New York Heart Association (NYHA) class <0.001) predicted the occurrence of ICD therapy on follow-up. In conclusion, in chronic ischemic patients with an ICD for primary prevention, the presence of diabetes, renal dysfunction, higher NYHA class, and impaired peri-infarct zone function were predictors of all-cause mortality. In contrast, only impaired peri-infarct zone function determined the occurrence of appropriate ICD therapy on follow-up.
|Persistent URL||dx.doi.org/10.1016/j.amjcard.2010.07.029, hdl.handle.net/1765/21947|
|Journal||The American Journal of Cardiology|
Ng, A.C.T, Bertini, M, Borleffs, C.J.W, Delgado, V, Boersma, H, & Piers, S.R.D. (2010). Predictors of death and occurrence of appropriate implantable defibrillator therapies in patients with ischemic cardiomyopathy. The American Journal of Cardiology, 106(11), 1566–1573. doi:10.1016/j.amjcard.2010.07.029